3
Announcements
Trials
Browse
Landscape
Status
Recruiting
52
Active not recruiting
15
Completed
14
Terminated
4
Withdrawn
1
Suspended
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
31
Prostatic Neoplasms
13
Breast Neoplasms
13
Colorectal Neoplasms
12
Hematologic Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lung Neoplasms
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Uterine Cervical Neoplasms
4
Pancreatic Neoplasms
4
Myasthenia Gravis
4
Melanoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma
4
Pain
3
Ovarian Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Diseases
3
Glioma
3
Gastrointestinal Neoplasms
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Anxiety Disorders
3
Urinary Bladder Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Kidney Neoplasms
×
90 days
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled